Caporali, Roberto, Roberto Ravasio, Paola Raimondo, and Fausto Salaffi. “Erratum In: Cost Per Responder for Upadacitinib Vs Abatacept in Patients With Moderate-to-Severe Rheumatoid Arthritis in Italy”. Global and Regional Health Technology Assessment 9, no. 1 (February 17, 2022): 30. Accessed July 3, 2024. https://journals.aboutscience.eu/index.php/grhta/article/view/2383.